Levitra Indications, Dosage, Storage, Stability - Vardenafil HCl

Levitra Indications, Dosage, Storage, Stability - Vardenafil HCl

INDICATIONS AND USAGE

LEVITRA is indicated for the treatment of erectile dysfunction.

For most patients, the recommended starting dose of LEVITRA is 10 mg, taken orally approximately 60 minutes before sexual activity. The dose may be increased to a maximum recommended dose of 20 mg or decreased to 5 mg based on efficacy and side effects. The maximum recommended dosing frequency is once per day. LEVITRA can be taken with or without food. Sexual stimulation is required for a response to treatment.

Geriatrics

A starting dose of 5 mg LEVITRA should be considered in patients ³ 65 years of age (see CLINICAL PHARMACOLOGY, Pharmacokinetics in Special Populations and PRECAUTIONS).

For patients with mild hepatic impairment (Child-Pugh A), no dose adjustment of LEVITRA is required. Vardenafil clearance is reduced in patients with moderate hepatic impairment (Child-Pugh B), and a starting dose of 5 mg LEVITRA is recommended. The maximum dose in patients with moderate hepatic impairment should not exceed 10 mg. LEVITRA has not been evaluated in patients with severe hepatic impairment (Child-Pugh C) (see CLINICAL PHARMACOLOGY, Metabolism and Excretion, WARNINGS and PRECAUTIONS).

For patients with mild (CL_cr = 50-80 ml/min), moderate (CL_cr = 30-50 ml/min), or severe (CL_cr <30 ml/min) renal impairment, no dose adjustment is required. LEVITRA has not been evaluated in patients on renal dialysis (see CLINICAL PHARMACOLOGY, Metabolism and Excretion and PRECAUTIONS).

The dosage of LEVITRA may require adjustment in patients receiving certain CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, indinavir, and erythromycin) (see WARNINGS, PRECAUTIONS, Drug Interactions). For ritonavir, a single dose of 2.5 mg LEVITRA should not be exceeded in a 72-hour period. For indinavir, ketoconazole 400 mg daily, and itraconazole 400 mg daily, a single dose of 2.5 mg LEVITRA should not be exceeded in a 24-hour period. For ketoconazole 200 mg daily, itraconazole 200 mg daily, and erythromycin, a single dose of 5 mg LEVITRA should not be exceeded in a 24-hour period.

LEVITRA (vardenafil HCl) is formulated as orange, film-coated round tablets with debossed "BAYER" cross on one side and "2.5", "5", "10", and "20" on the other side equivalent to 2.5 mg, 5 mg, 10 mg, and 20 mg of vardenafil, respectively.

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].

Manufactured by: Bayer Pharmaceuticals Corporation 400 Morgan Lane West Haven, CT 06516 Made in Germany, Distributed by: Schering Corporation Kenilworth, NJ 07033

LEVITRA is a registered trademark of Bayer Aktiengesellschaft and is used under license by Schering Corporation., 08918646, R.0, 10/04 12532 ©2004, Bayer Pharmaceuticals Corporation, Printed in U.S.A.